Firm News: Dec. 2015

Weitz & Luxenberg last month obtained a confidential multimillion-dollar settlement on behalf of a Queens, New York, man who sustained a traumatic brain injury, as well as other injuries, after falling from an apartment building’s second story walkway next to an apartment. The settlement came on the heels of a hard-won appellate victory that W&L…

Yet another breach of private consumer information has occurred and W&L is investigating the potential harm suffered by customers. This time, the source of the breach is Landry’s, Inc., with more than 500 outlets, including restaurants, hotels and casinos. This nationwide chain recently acknowledged that the credit card information of its customers has been stolen.…

On November 18, 2015, U.S. District Judge Kathryn H. Vratil of Kansas appointed the first plaintiffs steering committee (PSC) in a federal multidistrict litigation (MDL) with a majority of women members. This is a significant and appropriate achievement given that women comprise a large segment of the lawyers in the United States and about 50…

Weitz & Luxenberg, P.C., today announced that the firm has expanded the scope of its investigation into SGLT2 inhibitor drug injuries. SGLT2 inhibitor drugs include Invokana and others listed below. This move will allow the nationally known mass tort law and personal injury firm to focus on cases where people taking SGLT2 inhibitors were hospitalized…